付明强,常书福,秦晴,马剑英,葛均波

• 1:上海市心血管病研究所
• 2:复旦大学附属中山医院心内科

摘要(Abstract)：

急性ST段抬高型心肌梗死延迟开通闭塞靶血管的患者，术后发生无复流极为少见。本文报告1例右冠状动脉闭塞1个月后行支架置入术，术后反复无复流的案例，经导管血栓抽吸及冠状动脉内溶栓等多种方法联合治疗后成功恢复良好血流灌注。

关键词(KeyWords)： 冠状动脉闭塞;无复流;血栓抽吸;重组人尿激酶原

Abstract:

Keywords:

基金项目(Foundation): 上海申康医院发展中心市级医院临床研究培育项目（SHDC12018X05）

作者(Author): 付明强,常书福,秦晴,马剑英,葛均波

参考文献(References)：

• [1] Feher A, Chen SY, Bagi Z, et al. Prevention and treatment of norefl ow phenomenon by targeting the coronary microcirculation[J].Rev Cardiovasc Med, 2014, 15(1):38-51.
• [2] Rezkalla SH, Dharmashankar KC, Abdalrahman IB, et al. Norefl ow phenomenon following percutaneous coronary intervention for acute myocardial infarction:incidence, outcome, and eff ect of pharmacologic therapy[J]. J Interv Cardiol, 2010, 23(5):429-436.
• [3] Kumar J, O’Connor CT, Kumar R, et al. Coronary no-refl ow in the modern era:a review of advances in diagnostic techniques and contemporary management[J]. Expert Rev Cardiovasc Ther, 2019,17(8):605-623.
• [4] Avci E, Yildirim T, Aydin G, et al. Combining clinical predictors to better predict for the no-refl ow phenomenon[J]. Eur Rev Med Pharmacol Sci, 2018, 22(15):4987-4994.
• [5] Choo EH, Kim PJ, Chang K, et al. The impact of no-reflow phenomena after primary percutaneous coronary intervention:a time-dependent analysis of mortality[J]. Coron Artery Dis, 2014,25(5):392-398.
• [6] Wu X, Mintz GS, Xu K, et al. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction:the HORIZONS-AMI(harmonizing outcomes with revascularization and stents in acute myocardial infarction)trial[J]. JACC Cardiovasc Interv, 2011, 4(5):495-502.
• [7]陈艺，颜红兵.心肌缺血再灌注后无复流发生的分子机制[J].中国介入心脏病学杂志，2011,19(3):168-171.
• [8]林春尧，刘晓辉. D-二聚体联合CHA2DS2-VASc评分对老年急性心肌梗死患者介入术后无复流的预测价值[J].中华老年心脑血管病杂志，2020, 22(4):372-376.
• [9] Modolo R, Figueiredo VN, Moura FA, et al. Coronary artery calcification score is an independent predictor of the no-reflow phenomenon af ter reperf usion therapy in acute myocardial infarction[J]. Coron Artery Dis, 2015, 26(7):562-566.
• [10] Magro M, Nauta ST, Simsek C, et al. Usefulness of the SYNTAX score to predict"no reflow"in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J]. Am J Cardiol, 2012, 109(5):601-606.
• [11] Caiazzo G, Musci RL, Frediani L, et al. State of the art:no-refl ow phenomenon[J]. Cardiol Clin, 2020, 38(4):563-573.
• [12]郭丽霞，张兰，娄潇思，等.尼可地尔预处理对非ST段抬高型急性冠状动脉综合征患者无复流现象的预防效果[J].中国介入心脏病学杂志，2019, 27(3):140-144.
• [13] Lago IM, Novaes GC, Badran AV, et al. In-Lab upfront use of tirofiban may reduce the occurrence of no-reflow during primary percutaneous coronary intervention. A pilot randomized study[J].Arq Bras Cardiol, 2016, 107(5):403-410.
• [14] Liu X, Dong P, Xing S, et al. Clinical evaluation of thrombus aspiration combined with tirofi ban in patients with acute myocardial infarction with elective percutaneous coronary intervention[J]. J Int Med Res, 2013, 41(5):1532-1540.